Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 70/100

Kymera Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024

Tuesday, January 2, 2024 1 min read
Key Takeaway: Kymera Therapeutics, a clinical-stage biopharmaceutical company, is set to present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024. The company's Founder, President, and CEO, Nello Mainolfi, will discuss the organization's progress and expected milestones for the upcoming year. The presentation will be accessible via a live webcast, with a replay available for 30 days following the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics is advancing a new class of medicines.
  • The presentation may provide insights into the company's progress.
  • The event offers live and archived access for broader audience engagement.

Full Press Release Details

WATERTOWN, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 9, 2024, at 9:00 a.m. PT/12:00 p.m. ET. Nello Mainolfi, Ph.D., Founder, President and CEO, will provide an overview of the Company’s progress and anticipated milestones for 2024.
A live webcast of the presentation and Q&A session will be available under the "Events and Presentations" section of the Investors page on the Company's website at www.kymeratx.com. A replay of the webcast will be archived on Kymera’s website and available for 30-days following the event.
About Kymera Therapeutics

Frequently Asked Questions

When will Kymera Therapeutics present at the J.P. Morgan Conference?

Kymera Therapeutics will present on January 9, 2024, at 9:00 a.m. PT.

Who will represent Kymera at the conference?

Nello Mainolfi, Ph.D., will represent Kymera Therapeutics at the conference.

Where can I watch the presentation live?

The live webcast is available on Kymera's Investors page at kymeratx.com.

How long will the webcast replay be available?

The webcast replay will be archived for 30 days post-event on Kymera’s website.

What is the focus of Kymera Therapeutics?

Kymera Therapeutics focuses on targeted protein degradation (TPD) therapies.

Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics J.P. Morgan Conference biopharmaceutical Nello Mainolfi small molecule medicines
Last updated: Jan 2, 2024